CDS Surveillance Has Positive Clinical Impact, Research Indicates | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

CDS Surveillance Has Positive Clinical Impact, Research Indicates

August 7, 2013
by Gabriel Perna
| Reprints

According to the Orem, Utah-based research and consulting firm, KLAS Research, most providers that are using clinical decision support (CDS) surveillance systems say the technology has had a moderate to significant impact on clinical outcomes.

In total, 79 percent of providers (140 were surveyed for the report) say that CDS surveillance systems have led to mostly positive clinical outcomes. "Providers make it clear that they feel that CDS surveillance is having a positive impact on how well they are able to care for their patients," Adam Cherrington, research director and report author from KLAS, said in a statement. "This report doesn't just answer the question of whether CDS surveillance is having an impact on clinical outcomes; it also reveals which vendors are the best positioned and most effective at helping providers."

In the report, KLAS looked at a number of vendors, including Allscripts,Caradigm, Carefusion, Cerner, Epic, Hospira, Perahealth, Siemens, Truven Health Pharmacy, and Wolters Kluwer. KLAS broke the vendors into categories of pharmacy-focused surveillance, enterprise-wide surveillance and EMR surveillance.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



NIH to Fund Genome Centers for All of Us Program

In May 2018 the National Institutes of Health will solicit applications for large-scale Genome Centers to generate genomic data as part of the All of Us Research Program.

New York State’s PDMP Now Interoperable with 25 States and D.C.

New York Governor Andrew Cuomo announced this week new efforts to combat the opioid epidemic, including advancing partnerships in New York’s prescription monitoring program (PMP) across the country.

Report: Midwest Healthcare Companies Attracted $2.5B in Investments in 2017

Midwest healthcare companies attracted $2.5 billion in new equity investments in 2017, a 38 percent increase over 2016, according to the BioEnterprise Midwest Healthcare Growth Capital Report.

Research: Precision Medicine May Improve Survival in Late-Stage Cancer, Lower Costs

A precision medicine study conducted by researchers from Intermountain Precision Genomics and Stanford University School of Medicine indicates that precision oncology may improve overall survival and lower healthcare costs for advanced cancer patients.

Study: Researchers Use EHR Data to Predict Future Chronic Opioid Use

Researchers at the University of Colorado Anschutz Medical Campus are working to develop statistical models to better predict which patients will be prescribed opioid medications long-term following discharge from a hospital stay.

ONC Avoids 2018 Budget Cuts in New Spending Bill

The Office of the National Coordinator for Health IT’s (ONC) funding for 2018 will hold steady through September, at $60 million, as part of a House spending bill that was passed on Thursday.